Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Oncology CRO Services
Cyagen provides end-to-end oncology CRO services – from advanced animal models to comprehensive drug evaluation and translational insights. Our platform accelerates oncology research with customizable models and validated preclinical solutions.
One-Stop Oncology CRO Solutions
Cyagen provides comprehensive preclinical CRO solutions for oncology drug evaluation, supporting antibody drugs, cell and gene therapies, mRNA-based approaches, and more. Our platform covers the full workflow — from diverse tumor model generation (CDX, PDX, GEM, syngeneic, humanized) to in vivo efficacy studies and in vitro mechanistic assays. With extensive experience across 200+ oncology projects and support for IND applications, we help biopharma teams accelerate their oncology pipelines with confidence and precision.
{{ item.title }}
{{static_tabs[0].title}}
Cyagen delivers comprehensive in vivo efficacy evaluation services that simulate clinical settings with high fidelity. From tumor establishment to pharmacodynamic monitoring, our platform supports a wide spectrum of model types and therapeutic modalities—helping clients generate robust, IND-enabling preclinical data.
Base Strain
Search for Models
Search
Catalog Number Name Base Strain Research Application Action
{{ value.product_num || "--" }} {{ value.product_name || "--" }} {{ value.product_strain || "--" }} {{ value.research_application || "--" }} Inquire
Previous Page
Next Page
Need Customized Evaluation for Your Therapy?
If your desired neuroscience model isn’t listed, our experts are here to help! Request a Custom Animal Model >>
{{static_tabs[1].title}}
At Cyagen, we offer advanced in vivo drug delivery and phenotyping services tailored for ophthalmic studies. From precise ocular injections to high-resolution imaging and vision behavior analysis, our platform provides comprehensive capabilities to evaluate drug efficacy and safety. Supported by expert personnel and cutting-edge instrumentation, we ensure consistent, accurate, and reproducible preclinical results.
Customized Study Design
Designs tailored for evaluating mAbs, mRNA drugs, CAR-T/NK therapies, oncolytic viruses, and immune checkpoint inhibitors.
  • IND-ready timelines & professional consultation included.
Tumor Model Flexibility
Supports subcutaneous, orthotopic, hematologic, and metastatic tumor models using:
  • CDX (Cell-Derived Xenograft)
  • PDX (Patient-Derived Xenograft)
  • GEMM (Genetically Engineered Mouse Models)
  • Humanized Immune Mouse Models (e.g., huHSC-C-NKG-ProF)
Endpoints & Technologies
  • Tumor volume, body weight, survival
  • IVIS imaging (bioluminescence/fluorescence)
  • Flow cytometry, H&E, IHC, ELISA, qPCR
  • Customized readouts for mechanism-of-action or resistance studies
Need Customized Evaluation for Your Therapy?
Request In Vivo Drug Testing →
Case Examples
{{ item.label }}
{{item.context}}
{{ item.context }}
{{static_tabs[2].title}}
Cyagen offers a full suite of in vitro and ex vivo pharmacology services to support oncology drug discovery and mechanistic studies. These assays complement in vivo models, providing high-throughput, reproducible insights into drug cytotoxicity, immune act
Cytotoxicity & Immune Function Assays
  • LDH / CTG / CCK-8 viability and cytotoxicity tests
  • CAR-T/NK-mediated cell killing & activation
  • T/NK cell cytokine secretion and proliferation
  • Antibody-dependent cellular cytotoxicity (ADCC)
Molecular & Biomarker Detection
  • Western Blot, ELISA, qPCR for expression profiling
  • Cytokine panels via Singleplex (ELISA) and Multiplex (Luminex, MSD, FACS CBA)
  • DNA/RNA detection via digital PCR and molecular hybridization
Histology & Imaging-Based Analysis
  • H&E staining, immunohistochemistry (IHC)
  • Immunofluorescence (IF), dual/multiplex labeling
  • Fluorescence imaging for tissue localization & distribution
  • In vivo biodistribution via IVIS if applicable
Pharmacokinetics & Toxicity (Optional add-on)
  • Single or repeat dose toxicity testing
  • Genotoxicity, reproductive toxicity, carcinogenicity
  • Blood chemistry, organ indices, LC-UV bioanalysis
Looking to Validate Drug Mechanisms or Biomarkers?
Request In Vitro & Molecular Assays →
Case Examples
{{ item.label }}
{{item.context}}
{{ item.context }}
Our Unique Advantages
Broad Model Coverage for Translational Relevance
Cyagen provides one of the industry’s most extensive tumor model libraries—ranging from CDX, PDX, GEMM, to fully humanized immune mice—enabling clinically relevant assessments for diverse oncology pipelines.
End-to-End Evaluation from Efficacy to Mechanism
From tumor growth curves to biomarker analysis, we support every stage of your study with comprehensive endpoints—IVIS imaging, survival tracking, histology (H&E/IHC), qPCR, flow cytometry, and more.
Proven Success in IND-Enabling Projects
With 200+ oncology studies completed and multiple IND applications supported, our CRO platform combines validated workflows with expert guidance to accelerate your drug development with confidence.
Request a Preclinical CRO Services Consultation
Partner with Cyagen to advance your preclinical studies. Share your project goals with us and receive customized support.
Inquiry Details
Main Area of Research
Service(s) of Interest
Project Details
Contact Information
Full Name
Email
Phone Number
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest